Orchard Therapeutics plc

Orchard Therapeutics plcverified

ORTX

Price:

$16.7

Market Cap:

$380.11M

Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company's clinical development products comprise OTL-101 for the treatment of ADA-SCID; OTL-200 to treat metachromatic leukodystrophy; OTL-103 for the treatment of Wis...[Read more]

Industry

Biotechnology

IPO Date

2018-10-31

Stock Exchange

NASDAQ

Ticker

ORTX

The Enterprise Value as of November 2025 (TTM) for Orchard Therapeutics plc (ORTX) is 369.77M

According to Orchard Therapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is 369.77M. This represents a change of 254.88% compared to the average of 104.20M of the last 4 quarters.

Orchard Therapeutics plc (ORTX) Historical Enterprise Value (quarterly & annually)

How has ORTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Orchard Therapeutics plc over the last ten years is 307.73M. The current 369.77M Enterprise Value has changed 11.92% with respect to the historical average. Over the past ten years (40 quarters), ORTX's Enterprise Value was at its highest in in the December 2019 quarter at 1.38B. The Enterprise Value was at its lowest in in the December 2017 quarter at -89856000.00.

Quarterly (TTM)
Annual

Average

307.73M

Median

137.85M

Minimum

19.02M

Maximum

1.31B

Orchard Therapeutics plc (ORTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Orchard Therapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 6.78%

Maximum Annual Enterprise Value = 1.31B

Minimum Annual Increase = -77.86%

Minimum Annual Enterprise Value = 19.02M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202237.02M-77.86%
2021167.21M-61.35%
2020432.64M-66.95%
20191.31B6.78%
201819.02M-63.07%
201751.49M-62.65%

Orchard Therapeutics plc (ORTX) Average Enterprise Value

How has ORTX Enterprise Value performed in the past?

The current Enterprise Value of Orchard Therapeutics plc (ORTX) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

212.29M

5-year avg

392.96M

10-year avg

307.73M

Orchard Therapeutics plc (ORTX) Enterprise Value vs. Peers

How is ORTX’s Enterprise Value compared to its peers?

Orchard Therapeutics plc’s Enterprise Value is greater than Vigil Neuroscience, Inc. (346.93M), greater than Checkpoint Therapeutics, Inc. (334.68M), less than Revance Therapeutics, Inc. (805.89M), less than G1 Therapeutics, Inc. (402.64M), greater than Climb Bio, Inc. (95.92M), greater than Y-mAbs Therapeutics, Inc. (332.06M), greater than scPharmaceuticals Inc. (313.84M), greater than iTeos Therapeutics, Inc. (245.99M), greater than SomaLogic, Inc. (-23127083.00), less than Claritev Corporation (5.15B),

Build a custom stock screener for Orchard Therapeutics plc (ORTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orchard Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Orchard Therapeutics plc (ORTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Orchard Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Orchard Therapeutics plc's Enterprise Value?

What is the highest Enterprise Value for Orchard Therapeutics plc (ORTX)?

What is the 3-year average Enterprise Value for Orchard Therapeutics plc (ORTX)?

What is the 5-year average Enterprise Value for Orchard Therapeutics plc (ORTX)?

How does the current Enterprise Value for Orchard Therapeutics plc (ORTX) compare to its historical average?